Stock listing
Neural Therapeutics Inc.
Selected listing: HANF · FWB · EUR · DE
Neural Therapeutics Inc. (Frankfurt:HANF), Health Technology. Latest release Aug 14, 2026: Hanf.com Transaction Advances as Neural Therapeutics Receives CSE…
- Ticker
- Frankfurt:HANF
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Other
- Exchange
- Frankfurt
- Currency
- EUR
Latest news from Neural Therapeutics Inc.
Hanf.com Transaction Advances as Neural Therapeutics Receives CSE Conditional Approval
August 14, 2026
Neural Therapeutics Inc. Announces Transition to Semi-Annual Financial Reporting
June 19, 2026
Neural Therapeutics Announces AGSM Results, CFO Appointment and Welcomes Positive Developments in the German Cannabis Market
June 12, 2026
Neural Therapeutics Announces Filing and Mailing of Meeting Materials for Annual and Special Meeting to Approve Series B Transactions with CWE
May 1, 2026
Neural Therapeutics Announces Amendment to SIO Agreement, Concurrent Financing Terms, Shareholder Meeting Date and RSU Grant
March 27, 2026
Research Neural Therapeutics Inc.
Neural Therapeutics Inc. company profile
View the public company page for Neural Therapeutics Inc. on 6ix.
Neural Therapeutics Inc. news
Read company news and market updates connected to Neural Therapeutics Inc..
Neural Therapeutics Inc. investor events
Find investor webinars, events, and replay context for Neural Therapeutics Inc..
Alternate listings
NURL:CSE
CA · CAD
Alternate listing for Neural Therapeutics Inc.; the primary context on this page is HANF:FWB.
NURLF:OTC
US · USD
Alternate listing for Neural Therapeutics Inc.; the primary context on this page is HANF:FWB.
NURL:NEO
CA · CAD
Alternate listing for Neural Therapeutics Inc.; the primary context on this page is HANF:FWB.